Marine Biotechnology Market Size, Share, and Trends 2024 to 2034

The global marine biotechnology market size was USD 6.32 billion in 2023, calculated at USD 6.78 billion in 2024 and is expected to reach around USD 13.59 billion by 2034, expanding at a CAGR of 7.2% from 2024 to 2034.

  • Last Updated : August 2024
  • Report Code : 2614
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Marine Biotechnology Market 

5.1. COVID-19 Landscape: Marine Biotechnology Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Marine Biotechnology Market, By Source

8.1. Marine Biotechnology Market, by Source, 2024-2034

8.1.1 Corals and sponges

8.1.1.1. Market Revenue and Forecast (2021-2034)

8.1.2. Algae

8.1.2.1. Market Revenue and Forecast (2021-2034)

8.1.3. Marine Viruses

8.1.3.1. Market Revenue and Forecast (2021-2034)

8.1.4. Marine Fungi

8.1.4.1. Market Revenue and Forecast (2021-2034)

8.1.5. Others

8.1.5.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global Marine Biotechnology Market, By Application

9.1. Marine Biotechnology Market, by Application, 2024-2034

9.1.1. Aquaculture & Fishery

9.1.1.1. Market Revenue and Forecast (2021-2034)

9.1.2. Medicine

9.1.2.1. Market Revenue and Forecast (2021-2034)

9.1.3. Environment

9.1.3.1. Market Revenue and Forecast (2021-2034)

9.1.4. Biofuels

9.1.4.1. Market Revenue and Forecast (2021-2034)

9.1.5. Other

9.1.5.1. Market Revenue and Forecast (2021-2034)

Chapter 10. Global Marine Biotechnology Market, By End User 

10.1. Marine Biotechnology Market, by End User, 2024-2034

10.1.1. Medical & Pharmaceutical

10.1.1.1. Market Revenue and Forecast (2021-2034)

10.1.2. Food Industry

10.1.2.1. Market Revenue and Forecast (2021-2034)

10.1.3. Cosmetics Industry

10.1.3.1. Market Revenue and Forecast (2021-2034)

10.1.4. Chemical Industry

10.1.4.1. Market Revenue and Forecast (2021-2034)

10.1.5. Others

10.1.5.1. Market Revenue and Forecast (2021-2034)

Chapter 11. Global Marine Biotechnology Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Source (2021-2034)

11.1.2. Market Revenue and Forecast, by Application (2021-2034)

11.1.3. Market Revenue and Forecast, by End User (2021-2034)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Source (2021-2034)

11.1.4.2. Market Revenue and Forecast, by Application (2021-2034)

11.1.4.3. Market Revenue and Forecast, by End User (2021-2034)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Source (2021-2034)

11.1.5.2. Market Revenue and Forecast, by Application (2021-2034)

11.1.5.3. Market Revenue and Forecast, by End User (2021-2034)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Source (2021-2034)

11.2.2. Market Revenue and Forecast, by Application (2021-2034)

11.2.3. Market Revenue and Forecast, by End User (2021-2034)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Source (2021-2034)

11.2.4.2. Market Revenue and Forecast, by Application (2021-2034)

11.2.4.3. Market Revenue and Forecast, by End User (2021-2034)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Source (2021-2034)

11.2.5.2. Market Revenue and Forecast, by Application (2021-2034)

11.2.5.3. Market Revenue and Forecast, by End User (2021-2034)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Source (2021-2034)

11.2.6.2. Market Revenue and Forecast, by Application (2021-2034)

11.2.6.3. Market Revenue and Forecast, by End User (2021-2034)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Source (2021-2034)

11.2.7.2. Market Revenue and Forecast, by Application (2021-2034)

11.2.7.3. Market Revenue and Forecast, by End User (2021-2034)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Source (2021-2034)

11.3.2. Market Revenue and Forecast, by Application (2021-2034)

11.3.3. Market Revenue and Forecast, by End User (2021-2034)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Source (2021-2034)

11.3.4.2. Market Revenue and Forecast, by Application (2021-2034)

11.3.4.3. Market Revenue and Forecast, by End User (2021-2034)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Source (2021-2034)

11.3.5.2. Market Revenue and Forecast, by Application (2021-2034)

11.3.5.3. Market Revenue and Forecast, by End User (2021-2034)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Source (2021-2034)

11.3.6.2. Market Revenue and Forecast, by Application (2021-2034)

11.3.6.3. Market Revenue and Forecast, by End User (2021-2034)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Source (2021-2034)

11.3.7.2. Market Revenue and Forecast, by Application (2021-2034)

11.3.7.3. Market Revenue and Forecast, by End User (2021-2034)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Source (2021-2034)

11.4.2. Market Revenue and Forecast, by Application (2021-2034)

11.4.3. Market Revenue and Forecast, by End User (2021-2034)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Source (2021-2034)

11.4.4.2. Market Revenue and Forecast, by Application (2021-2034)

11.4.4.3. Market Revenue and Forecast, by End User (2021-2034)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Source (2021-2034)

11.4.5.2. Market Revenue and Forecast, by Application (2021-2034)

11.4.5.3. Market Revenue and Forecast, by End User (2021-2034)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Source (2021-2034)

11.4.6.2. Market Revenue and Forecast, by Application (2021-2034)

11.4.6.3. Market Revenue and Forecast, by End User (2021-2034)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Source (2021-2034)

11.4.7.2. Market Revenue and Forecast, by Application (2021-2034)

11.4.7.3. Market Revenue and Forecast, by End User (2021-2034)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Source (2021-2034)

11.5.2. Market Revenue and Forecast, by Application (2021-2034)

11.5.3. Market Revenue and Forecast, by End User (2021-2034)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Source (2021-2034)

11.5.4.2. Market Revenue and Forecast, by Application (2021-2034)

11.5.4.3. Market Revenue and Forecast, by End User (2021-2034)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Source (2021-2034)

11.5.5.2. Market Revenue and Forecast, by Application (2021-2034)

11.5.5.3. Market Revenue and Forecast, by End User (2021-2034)

Chapter 12. Company Profiles

12.1. Aker BioMarine AS

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Aqua Biotechnology ASA

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. BASF SE

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. BioLume, Inc.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Biotech Marine

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. CP Kelco

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Cyanotech Corp.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. GlycoMar Ltd.

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Lonza Group Ltd.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Marinova Pty Ltd

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client